MedPath

FENTANYL

These highlights do not include all the information needed to use FENTANYL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for FENTANYL TRANSDERMAL SYSTEM. FENTANYL transdermal system, CII Initial U.S. Approval: 1968

Approved
Approval ID

0ff70df0-2cda-d96c-42a8-3bf180310498

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 13, 2023

Manufacturers
FDA

Apotex Corp.

DUNS: 845263701

Products 10

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

FENTANYL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60505-7015
Application NumberANDA077449
Product Classification
M
Marketing Category
C73584
G
Generic Name
FENTANYL
Product Specifications
Route of AdministrationTRANSDERMAL
Effective DateJuly 13, 2023
FDA Product Classification

INGREDIENTS (5)

ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJS
Classification: IACT
OCTYLDODECANOLInactive
Code: 461N1O614Y
Classification: IACT
FENTANYLActive
Quantity: 37.5 ug in 1 h
Code: UF599785JZ
Classification: ACTIB
POLYBUTENE (1400 MW)Inactive
Code: 1NA5AO9GH7
Classification: IACT
POLYISOBUTYLENE (800000 MW)Inactive
Code: Y132ZOQ9H7
Classification: IACT

FENTANYL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60505-7007
Application NumberANDA077449
Product Classification
M
Marketing Category
C73584
G
Generic Name
FENTANYL
Product Specifications
Route of AdministrationTRANSDERMAL
Effective DateJuly 13, 2023
FDA Product Classification

INGREDIENTS (5)

ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJS
Classification: IACT
POLYBUTENE (1400 MW)Inactive
Code: 1NA5AO9GH7
Classification: IACT
POLYISOBUTYLENE (800000 MW)Inactive
Code: Y132ZOQ9H7
Classification: IACT
OCTYLDODECANOLInactive
Code: 461N1O614Y
Classification: IACT
FENTANYLActive
Quantity: 50 ug in 1 h
Code: UF599785JZ
Classification: ACTIB

FENTANYL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60505-7011
Application NumberANDA077449
Product Classification
M
Marketing Category
C73584
G
Generic Name
FENTANYL
Product Specifications
Route of AdministrationTRANSDERMAL
Effective DateJuly 13, 2023
FDA Product Classification

INGREDIENTS (5)

ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJS
Classification: IACT
POLYISOBUTYLENE (800000 MW)Inactive
Code: Y132ZOQ9H7
Classification: IACT
POLYBUTENE (1400 MW)Inactive
Code: 1NA5AO9GH7
Classification: IACT
OCTYLDODECANOLInactive
Code: 461N1O614Y
Classification: IACT
FENTANYLActive
Quantity: 25 ug in 1 h
Code: UF599785JZ
Classification: ACTIB

FENTANYL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60505-7006
Application NumberANDA077449
Product Classification
M
Marketing Category
C73584
G
Generic Name
FENTANYL
Product Specifications
Route of AdministrationTRANSDERMAL
Effective DateJuly 13, 2023
FDA Product Classification

INGREDIENTS (5)

ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJS
Classification: IACT
OCTYLDODECANOLInactive
Code: 461N1O614Y
Classification: IACT
POLYBUTENE (1400 MW)Inactive
Code: 1NA5AO9GH7
Classification: IACT
FENTANYLActive
Quantity: 25 ug in 1 h
Code: UF599785JZ
Classification: ACTIB
POLYISOBUTYLENE (800000 MW)Inactive
Code: Y132ZOQ9H7
Classification: IACT

FENTANYL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60505-7013
Application NumberANDA077449
Product Classification
M
Marketing Category
C73584
G
Generic Name
FENTANYL
Product Specifications
Route of AdministrationTRANSDERMAL
Effective DateJuly 13, 2023
FDA Product Classification

INGREDIENTS (5)

POLYISOBUTYLENE (800000 MW)Inactive
Code: Y132ZOQ9H7
Classification: IACT
FENTANYLActive
Quantity: 75 ug in 1 h
Code: UF599785JZ
Classification: ACTIB
OCTYLDODECANOLInactive
Code: 461N1O614Y
Classification: IACT
ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJS
Classification: IACT
POLYBUTENE (1400 MW)Inactive
Code: 1NA5AO9GH7
Classification: IACT

FENTANYL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60505-7016
Application NumberANDA077449
Product Classification
M
Marketing Category
C73584
G
Generic Name
FENTANYL
Product Specifications
Route of AdministrationTRANSDERMAL
Effective DateJuly 13, 2023
FDA Product Classification

INGREDIENTS (5)

ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJS
Classification: IACT
OCTYLDODECANOLInactive
Code: 461N1O614Y
Classification: IACT
POLYBUTENE (1400 MW)Inactive
Code: 1NA5AO9GH7
Classification: IACT
POLYISOBUTYLENE (800000 MW)Inactive
Code: Y132ZOQ9H7
Classification: IACT
FENTANYLActive
Quantity: 62.5 ug in 1 h
Code: UF599785JZ
Classification: ACTIB

FENTANYL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60505-7008
Application NumberANDA077449
Product Classification
M
Marketing Category
C73584
G
Generic Name
FENTANYL
Product Specifications
Route of AdministrationTRANSDERMAL
Effective DateJuly 13, 2023
FDA Product Classification

INGREDIENTS (5)

ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJS
Classification: IACT
OCTYLDODECANOLInactive
Code: 461N1O614Y
Classification: IACT
POLYBUTENE (1400 MW)Inactive
Code: 1NA5AO9GH7
Classification: IACT
POLYISOBUTYLENE (800000 MW)Inactive
Code: Y132ZOQ9H7
Classification: IACT
FENTANYLActive
Quantity: 75 ug in 1 h
Code: UF599785JZ
Classification: ACTIB

FENTANYL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60505-7009
Application NumberANDA077449
Product Classification
M
Marketing Category
C73584
G
Generic Name
FENTANYL
Product Specifications
Route of AdministrationTRANSDERMAL
Effective DateJuly 13, 2023
FDA Product Classification

INGREDIENTS (5)

ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJS
Classification: IACT
OCTYLDODECANOLInactive
Code: 461N1O614Y
Classification: IACT
FENTANYLActive
Quantity: 100 ug in 1 h
Code: UF599785JZ
Classification: ACTIB
POLYBUTENE (1400 MW)Inactive
Code: 1NA5AO9GH7
Classification: IACT
POLYISOBUTYLENE (800000 MW)Inactive
Code: Y132ZOQ9H7
Classification: IACT

FENTANYL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60505-7010
Application NumberANDA077449
Product Classification
M
Marketing Category
C73584
G
Generic Name
FENTANYL
Product Specifications
Route of AdministrationTRANSDERMAL
Effective DateJuly 13, 2023
FDA Product Classification

INGREDIENTS (5)

POLYISOBUTYLENE (800000 MW)Inactive
Code: Y132ZOQ9H7
Classification: IACT
ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJS
Classification: IACT
OCTYLDODECANOLInactive
Code: 461N1O614Y
Classification: IACT
POLYBUTENE (1400 MW)Inactive
Code: 1NA5AO9GH7
Classification: IACT
FENTANYLActive
Quantity: 12 ug in 1 h
Code: UF599785JZ
Classification: ACTIB

FENTANYL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60505-7017
Application NumberANDA077449
Product Classification
M
Marketing Category
C73584
G
Generic Name
FENTANYL
Product Specifications
Route of AdministrationTRANSDERMAL
Effective DateJuly 13, 2023
FDA Product Classification

INGREDIENTS (5)

ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJS
Classification: IACT
OCTYLDODECANOLInactive
Code: 461N1O614Y
Classification: IACT
POLYBUTENE (1400 MW)Inactive
Code: 1NA5AO9GH7
Classification: IACT
FENTANYLActive
Quantity: 87.5 ug in 1 h
Code: UF599785JZ
Classification: ACTIB
POLYISOBUTYLENE (800000 MW)Inactive
Code: Y132ZOQ9H7
Classification: IACT

Drug Labeling Information

RECENT MAJOR CHANGES SECTION

LOINC: 43683-2Updated: 10/31/2018

RECENT MAJOR CHANGES

Dosage and Administration ( 2) 1/2018

Boxed Warning 09/2018

Warnings and Precautions ( 5.2) 09/2019

Key Highlight

Dosage and Administration ( 2) 1/2018

Boxed Warning 09/2018

Warnings and Precautions ( 5.2) 09/2019

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.